HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Javanshir Esfandyari Selected Research

IBL-302

1/2020Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.
1/2019Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Javanshir Esfandyari Research Topics

Disease

4Neuroblastoma
10/2022 - 01/2019
3Neoplasms (Cancer)
08/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

2IBL-302IBA
01/2020 - 01/2019
2Phosphotransferases (Kinase)IBA
01/2020 - 01/2019
1ON 01910IBA
08/2021
1N-Myc Proto-Oncogene ProteinIBA
01/2019
1Cisplatin (Platino)FDA LinkGeneric
01/2019

Therapy/Procedure

2Drug Therapy (Chemotherapy)
10/2022 - 01/2019
1Therapeutics
01/2019